Bforcure
The future of biosensing and biological diagnostics to protect health and planet.
- dt and ls
- biotechnology
- horizon europe
- sustainable development goals
- climate tech
- radar de l'innovation
- testing
- tech for business
- observatoire industrial tech
- observatoire deeptech
- medical testing
- biotech, medtech and e-health
- nif defense security and resilience
- water tech
- tech for biotech and pharma
- observatoire healthtech
- water monitoring
- nif health crisis preparedness
- nif biotech
- water quality
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| N/A | €8.2m | Series A | |
| Total Funding | 000k | ||
| EUR | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 1290 % | 22 % | 72 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | (29 %) | - | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 174 % | 57 % | - | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
BforCure operates in the deeptech sector, focusing on microbiota research to address critical challenges in health, agriculture, resource preservation, and security. The company designs and commercializes advanced products that enable rapid identification and characterization of microorganisms, crucial for understanding microbiomes' roles in various fields. BforCure's technologies are particularly beneficial for CBRN safety professionals, offering enhanced detection accuracy and swift response capabilities to ensure optimal protection against complex threats. Additionally, the company supports the food and beverage industry, specifically winemaking, by improving the precision and quality of microorganism analyses throughout the production process. BforCure's business model revolves around leveraging patented breakthroughs to create highly valued products, serving clients in sectors that require advanced microbiological analysis. Revenue is generated through the commercialization of these specialized products, which cater to the needs of professionals in health, agriculture, and security markets. Keywords: microbiota, deeptech, microorganism, health, agriculture, security, CBRN, winemaking, analysis, commercialization.